N
Novo Nordisk A/S
Q1 2026 earnings
Quarter
Jan – Mar
Released
May 6, 2026(ET)
Revenue
This quarter$15.0B
Analyst estimate$70.5B▼ -78.8%
Year ago (Mar '25)$11.3B▲ +32.3%
EPS
This quarter$1.04
Analyst estimate$5.74▼ -81.9%
Year ago (Mar '25)$0.92▲ +13.0%
Revenue Growth Trajectory
+32%YoY
Last 7 quarters
Related to this earnings
3 Dividend Stocks That Are No-Brainer Buys Heading Into the Second Half of 2026Jul 11
A tiny GLP-1 implant is the latest bet to help patients maintain their weight lossJul 11
NVO Rallies 11% in a Month: How Should Investors Play the Stock?Jul 10
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should KnowJul 10
Novo Nordisk: Why I Don't Think The Story Is BrokenJul 9
